TOX and pulmonary fibrosis: To validate the chip-derived findings in vivo, pulmonary fibrosis was induced in 4-week-old male C57BL/6 mice via intratracheal administration of bleomycin (1.25 U kg−1) or recombinant TOX (0.1 mg mL−1).